FDA Inspection
IndeCon, Inc.IndeCon, Inc. – FDA Inspection, Dec 12, 2024
Record Details
This FDA Inspection record concerns IndeCon, Inc., with an inspection on December 12, 2024, issued by the Dallas District Office, covering biologics.
View Company Profile
ID · d75d58fc-1bd4-44ad-bbe6-a64f8feebaba
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1256367
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.55(d)(4)Ten year retention
- 21 CFR 1271.270(a)Records maintained concurrently
- 21 CFR 1271.260(e)Storage temperatures recorded, maintained
Full citation text and observation details available on the Dashboard.
Other FDA inspections of IndeCon, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 22, 2016 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 29, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for IndeCon, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.